Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Jeffrey Montgomery

Concepts (437)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Urinary Bladder Neoplasms
52
2024
158
9.900
 Why?
Cystectomy
31
2024
49
6.320
 Why?
Prostatic Neoplasms
43
2024
393
5.090
 Why?
Kidney Neoplasms
22
2018
173
2.790
 Why?
Carcinoma, Transitional Cell
13
2023
52
2.700
 Why?
Prostatectomy
22
2023
82
2.370
 Why?
Nephrectomy
19
2016
81
2.000
 Why?
Lymph Node Excision
7
2024
138
1.830
 Why?
Urinary Diversion
6
2021
44
1.640
 Why?
Prostate
14
2024
117
1.550
 Why?
Laparoscopy
13
2014
170
1.550
 Why?
Quality of Life
12
2023
843
1.460
 Why?
Aged
81
2024
9505
1.360
 Why?
Male
120
2024
25572
1.270
 Why?
Middle Aged
87
2024
12356
1.210
 Why?
Humans
149
2024
50201
1.190
 Why?
Neoadjuvant Therapy
12
2024
119
1.140
 Why?
Neoplasm Staging
25
2024
749
1.030
 Why?
BCG Vaccine
7
2024
16
0.980
 Why?
Robotics
8
2015
41
0.970
 Why?
Postoperative Complications
15
2021
1027
0.930
 Why?
Retrospective Studies
52
2024
6190
0.930
 Why?
Carcinoma, Renal Cell
10
2016
101
0.910
 Why?
Penile Neoplasms
3
2024
45
0.890
 Why?
Exercise Therapy
1
2023
94
0.830
 Why?
Ureter
3
2016
37
0.820
 Why?
Exercise
2
2023
504
0.820
 Why?
Hernia
2
2020
6
0.780
 Why?
Neoplasm Recurrence, Local
15
2024
630
0.720
 Why?
Intestine, Small
2
2020
111
0.720
 Why?
Herniorrhaphy
1
2020
23
0.700
 Why?
Treatment Outcome
30
2024
5203
0.700
 Why?
Physical Fitness
1
2020
56
0.690
 Why?
Intestinal Obstruction
1
2020
36
0.680
 Why?
Patient Readmission
6
2021
222
0.680
 Why?
Aged, 80 and over
26
2024
3158
0.670
 Why?
Image-Guided Biopsy
6
2024
33
0.660
 Why?
Watchful Waiting
7
2019
27
0.640
 Why?
Biopsy
17
2023
592
0.620
 Why?
Ureteral Neoplasms
2
2018
11
0.610
 Why?
Neoplasm Invasiveness
14
2024
269
0.610
 Why?
Female
59
2024
26829
0.580
 Why?
Urinary Bladder
7
2018
93
0.550
 Why?
Magnetic Resonance Imaging
10
2023
1529
0.550
 Why?
Testicular Neoplasms
4
2024
64
0.550
 Why?
Convalescence
1
2016
6
0.540
 Why?
Carcinoma, Squamous Cell
4
2024
330
0.530
 Why?
Neoplasms, Germ Cell and Embryonal
3
2024
36
0.500
 Why?
Prospective Studies
17
2024
2396
0.490
 Why?
Urothelium
4
2018
18
0.490
 Why?
Carcinoma in Situ
4
2024
73
0.490
 Why?
Chemotherapy, Adjuvant
8
2024
121
0.480
 Why?
Ileum
1
2014
87
0.470
 Why?
Urologic Neoplasms
3
2019
12
0.470
 Why?
Choline
3
2019
63
0.460
 Why?
Neoplasm Grading
13
2020
123
0.450
 Why?
Medical Oncology
4
2021
96
0.450
 Why?
Quality Indicators, Health Care
1
2013
86
0.410
 Why?
Needles
3
2021
24
0.400
 Why?
Administration, Intravesical
7
2024
16
0.390
 Why?
Urologic Surgical Procedures
3
2016
27
0.390
 Why?
Disease Progression
8
2024
821
0.390
 Why?
Antineoplastic Agents
3
2021
1176
0.390
 Why?
Lymphatic Metastasis
4
2024
226
0.380
 Why?
Survival Rate
9
2021
906
0.370
 Why?
Biopsy, Needle
5
2021
182
0.370
 Why?
Prostate-Specific Antigen
8
2021
47
0.370
 Why?
Testicular Diseases
1
2011
4
0.370
 Why?
Risk Assessment
10
2019
1255
0.370
 Why?
Urogenital Neoplasms
1
2010
9
0.360
 Why?
Tumor Burden
6
2016
131
0.360
 Why?
Magnetic Resonance Imaging, Interventional
4
2024
5
0.350
 Why?
Muscle Neoplasms
1
2010
16
0.350
 Why?
Registries
4
2023
527
0.350
 Why?
Fluorine Radioisotopes
2
2019
24
0.330
 Why?
Retroperitoneal Space
5
2016
32
0.330
 Why?
Antineoplastic Combined Chemotherapy Protocols
4
2024
1000
0.330
 Why?
Adult
27
2024
13486
0.330
 Why?
Recovery of Function
2
2023
188
0.330
 Why?
Psoas Muscles
2
2021
2
0.320
 Why?
Self Report
1
2010
202
0.320
 Why?
Organ Sparing Treatments
4
2018
55
0.320
 Why?
Telomerase
2
2019
26
0.310
 Why?
Patient Selection
5
2019
254
0.310
 Why?
Urinary Incontinence
3
2023
38
0.300
 Why?
Deoxycytidine
3
2024
28
0.290
 Why?
Seat Belts
2
2017
17
0.290
 Why?
Child Restraint Systems
2
2017
18
0.290
 Why?
Urinary Catheterization
1
2007
24
0.290
 Why?
Positron-Emission Tomography
2
2019
288
0.290
 Why?
Urethral Stricture
1
2007
21
0.290
 Why?
Time Factors
13
2020
2909
0.280
 Why?
Primary Health Care
1
2011
363
0.280
 Why?
Rectum
2
2024
52
0.280
 Why?
Cohort Studies
8
2021
1414
0.270
 Why?
Tomography, X-Ray Computed
3
2021
1160
0.270
 Why?
Guideline Adherence
3
2017
133
0.270
 Why?
Length of Stay
6
2020
627
0.270
 Why?
Health Status
2
2015
299
0.260
 Why?
Pain Measurement
2
2017
246
0.260
 Why?
Patient Discharge
3
2017
322
0.260
 Why?
Kidney
4
2014
677
0.250
 Why?
Patient Participation
2
2016
67
0.250
 Why?
Bandages
1
2005
25
0.240
 Why?
Carcinoma
2
2018
139
0.240
 Why?
Adenoviridae
2
2024
49
0.240
 Why?
Surgical Wound Infection
1
2005
116
0.240
 Why?
Neurilemmoma
1
2004
24
0.240
 Why?
Quality Improvement
3
2016
206
0.230
 Why?
Age Factors
7
2021
1096
0.230
 Why?
Antimetabolites, Antineoplastic
1
2024
37
0.230
 Why?
Multivariate Analysis
8
2016
581
0.230
 Why?
Adenocarcinoma
3
2016
402
0.230
 Why?
Organoids
1
2024
36
0.230
 Why?
Immunohistochemistry
5
2024
973
0.230
 Why?
Venous Thrombosis
1
2005
88
0.230
 Why?
Follow-Up Studies
9
2024
2188
0.230
 Why?
Perineum
1
2024
24
0.230
 Why?
Decision Making
2
2016
273
0.220
 Why?
Antibiotic Prophylaxis
1
2024
61
0.220
 Why?
Clinical Competence
3
2016
397
0.210
 Why?
Practice Guidelines as Topic
2
2018
459
0.210
 Why?
Prognosis
9
2021
1963
0.200
 Why?
Urethra
3
2014
91
0.200
 Why?
Erectile Dysfunction
3
2023
87
0.200
 Why?
United States
12
2020
4898
0.200
 Why?
DNA, Neoplasm
2
2018
146
0.200
 Why?
Logistic Models
7
2021
901
0.190
 Why?
Vital Statistics
1
2021
3
0.190
 Why?
Mandatory Reporting
1
2021
12
0.190
 Why?
Death Certificates
1
2021
17
0.190
 Why?
Feasibility Studies
2
2020
383
0.190
 Why?
DNA Mutational Analysis
3
2018
176
0.190
 Why?
Birth Certificates
1
2021
20
0.190
 Why?
Cell Transdifferentiation
1
2021
8
0.190
 Why?
Neuroendocrine Cells
1
2021
10
0.190
 Why?
Cost-Benefit Analysis
2
2019
270
0.190
 Why?
Reproducibility of Results
7
2018
1195
0.180
 Why?
Urethral Diseases
2
2013
7
0.180
 Why?
Radiosurgery
1
2022
121
0.180
 Why?
Radiography, Abdominal
1
2020
27
0.180
 Why?
Mutation
5
2019
1288
0.180
 Why?
Reimbursement, Incentive
1
2020
13
0.180
 Why?
Genetic Vectors
1
2020
126
0.170
 Why?
Randomized Controlled Trials as Topic
4
2023
553
0.170
 Why?
Genetic Therapy
1
2020
117
0.170
 Why?
Ablation Techniques
1
2019
22
0.170
 Why?
Abdominal Pain
1
2020
84
0.170
 Why?
Venous Thromboembolism
1
2020
67
0.160
 Why?
Diagnosis, Differential
2
2020
1041
0.160
 Why?
Genetic Predisposition to Disease
5
2024
508
0.160
 Why?
Adjuvants, Immunologic
3
2024
51
0.160
 Why?
Urinary Tract
1
2018
26
0.160
 Why?
Predictive Value of Tests
6
2018
921
0.160
 Why?
Forecasting
1
2019
145
0.160
 Why?
Lymphocytes
1
2019
154
0.160
 Why?
Patient-Centered Care
1
2020
129
0.160
 Why?
Obesity
2
2006
1112
0.160
 Why?
RNA, Neoplasm
1
2018
45
0.150
 Why?
Genetic Heterogeneity
1
2018
18
0.150
 Why?
Drug Resistance, Neoplasm
1
2020
315
0.150
 Why?
Neutrophils
1
2019
148
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2018
40
0.150
 Why?
Retroperitoneal Neoplasms
1
2018
20
0.150
 Why?
Orchiectomy
1
2018
41
0.150
 Why?
Transurethral Resection of Prostate
1
2018
10
0.150
 Why?
Internship and Residency
2
2021
443
0.150
 Why?
Pain, Postoperative
2
2016
160
0.150
 Why?
Body Size
1
2017
27
0.150
 Why?
Electronic Health Records
1
2020
208
0.150
 Why?
Quality Assurance, Health Care
1
2018
149
0.140
 Why?
Anticoagulants
1
2020
253
0.140
 Why?
Physician-Patient Relations
2
2016
143
0.140
 Why?
Databases, Factual
2
2021
660
0.140
 Why?
Inguinal Canal
1
2017
11
0.140
 Why?
Urodynamics
2
2014
23
0.140
 Why?
Sarcosine
1
2017
3
0.140
 Why?
Amino Acid Transport Systems
1
2017
5
0.140
 Why?
Body Height
1
2017
65
0.140
 Why?
Carbon Radioisotopes
1
2017
53
0.140
 Why?
Transcriptome
2
2018
316
0.140
 Why?
Safety
1
2017
77
0.140
 Why?
Guidelines as Topic
1
2017
110
0.140
 Why?
Disease-Free Survival
5
2016
450
0.140
 Why?
Replantation
1
2016
11
0.140
 Why?
Scrotum
2
2015
30
0.140
 Why?
Protons
1
2017
67
0.140
 Why?
Nomograms
1
2016
4
0.130
 Why?
Laparotomy
1
2016
35
0.130
 Why?
Natural Orifice Endoscopic Surgery
1
2016
4
0.130
 Why?
Research Report
1
2016
16
0.130
 Why?
Kaplan-Meier Estimate
5
2017
463
0.130
 Why?
Physicians
2
2016
229
0.130
 Why?
Patient Preference
1
2016
38
0.130
 Why?
Urinary Retention
2
2007
7
0.130
 Why?
Checklist
1
2016
30
0.130
 Why?
Ureteral Obstruction
1
2016
61
0.130
 Why?
Time-to-Treatment
1
2016
70
0.130
 Why?
Preoperative Period
3
2021
47
0.130
 Why?
Genital Neoplasms, Male
1
2015
2
0.120
 Why?
Paget Disease, Extramammary
1
2015
5
0.120
 Why?
Sensitivity and Specificity
5
2018
871
0.120
 Why?
Social Networking
1
2015
15
0.120
 Why?
Body Weight
1
2017
513
0.120
 Why?
Lymph Nodes
1
2017
258
0.120
 Why?
Feedback
1
2015
52
0.120
 Why?
Radiopharmaceuticals
1
2016
205
0.120
 Why?
Video Recording
1
2015
79
0.120
 Why?
Treatment Failure
2
2017
116
0.120
 Why?
Peer Group
1
2015
54
0.120
 Why?
Informed Consent
1
2015
97
0.120
 Why?
Papilloma, Inverted
1
2014
1
0.120
 Why?
Proto-Oncogene Proteins B-raf
1
2015
78
0.120
 Why?
Equipment Design
3
2021
290
0.120
 Why?
Computer Simulation
1
2015
281
0.110
 Why?
Proto-Oncogene Proteins p21(ras)
1
2014
66
0.110
 Why?
Matched-Pair Analysis
1
2013
11
0.110
 Why?
Blood Loss, Surgical
5
2016
73
0.110
 Why?
Kidney Diseases
1
2016
212
0.110
 Why?
Urinary Incontinence, Stress
1
2014
30
0.110
 Why?
Body Mass Index
3
2020
658
0.110
 Why?
Diffusion of Innovation
1
2013
45
0.110
 Why?
Adenoma
1
2015
111
0.110
 Why?
Carcinoma, Papillary
1
2014
49
0.110
 Why?
General Surgery
1
2015
107
0.110
 Why?
Technology Transfer
1
2013
2
0.110
 Why?
Longitudinal Studies
2
2018
700
0.110
 Why?
Mitomycin
1
2013
20
0.110
 Why?
Radiotherapy, Adjuvant
2
2018
60
0.110
 Why?
Accreditation
1
2013
59
0.100
 Why?
Severity of Illness Index
2
2014
959
0.100
 Why?
Education, Medical, Continuing
1
2013
68
0.100
 Why?
Peripheral Nerves
1
2013
48
0.100
 Why?
Operating Rooms
1
2012
27
0.100
 Why?
Community Health Centers
1
2012
30
0.100
 Why?
Referral and Consultation
2
2012
284
0.100
 Why?
Pathology, Clinical
1
2012
24
0.100
 Why?
Receptors, Androgen
2
2002
46
0.100
 Why?
Algorithms
1
2015
615
0.100
 Why?
Combined Modality Therapy
3
2021
639
0.100
 Why?
Neoplasms
1
2021
1233
0.090
 Why?
Risk Factors
5
2017
3644
0.090
 Why?
Perioperative Care
1
2011
42
0.090
 Why?
Seminal Vesicles
2
2022
13
0.090
 Why?
Skin Neoplasms
1
2015
487
0.080
 Why?
Multicenter Studies as Topic
2
2023
88
0.080
 Why?
Medicare
3
2020
245
0.080
 Why?
Phantoms, Imaging
2
2020
122
0.080
 Why?
Proportional Hazards Models
3
2016
408
0.080
 Why?
Markov Chains
2
2019
31
0.080
 Why?
Carboplatin
2
2022
51
0.080
 Why?
SEER Program
3
2014
93
0.080
 Why?
Immunotherapy
1
2010
235
0.080
 Why?
Postoperative Care
2
2020
105
0.080
 Why?
Healthcare Disparities
1
2011
279
0.080
 Why?
Ureteroscopy
1
2007
12
0.070
 Why?
Automobiles
2
2017
14
0.070
 Why?
Sarcopenia
2
2021
94
0.070
 Why?
Incidence
2
2021
1000
0.070
 Why?
Pandemics
2
2023
567
0.070
 Why?
Chi-Square Distribution
3
2013
280
0.070
 Why?
Diverticulum
1
2007
21
0.070
 Why?
Peritoneum
1
2007
17
0.070
 Why?
Cisplatin
2
2022
275
0.070
 Why?
Delphi Technique
2
2018
54
0.070
 Why?
Gene Amplification
2
2018
57
0.070
 Why?
Societies, Medical
2
2018
177
0.070
 Why?
Aftercare
2
2018
74
0.070
 Why?
Gene Expression Profiling
2
2024
1029
0.070
 Why?
Adrenalectomy
1
2006
35
0.070
 Why?
Postoperative Hemorrhage
1
2006
52
0.070
 Why?
Promoter Regions, Genetic
2
2019
466
0.070
 Why?
Case-Control Studies
3
2014
1145
0.070
 Why?
Sex Factors
2
2020
700
0.060
 Why?
Fibrin Tissue Adhesive
1
2005
12
0.060
 Why?
Tissue Adhesives
1
2005
13
0.060
 Why?
Hand
1
2005
50
0.060
 Why?
Intestines
1
2006
171
0.060
 Why?
Genomics
2
2018
284
0.060
 Why?
Suture Techniques
1
2005
59
0.060
 Why?
Renal Insufficiency
1
2005
108
0.060
 Why?
Diabetes Complications
1
2005
118
0.060
 Why?
Chromosomes, Human, Pair 12
1
2024
14
0.060
 Why?
Glomerular Filtration Rate
2
2016
111
0.060
 Why?
Vulnerable Populations
1
2024
46
0.060
 Why?
Drug Screening Assays, Antitumor
1
2024
131
0.060
 Why?
Superior Mesenteric Artery Syndrome
1
2004
4
0.060
 Why?
Mediastinal Neoplasms
1
2024
19
0.060
 Why?
Communication
2
2016
246
0.060
 Why?
Phenotype
2
2018
732
0.060
 Why?
Hernia, Inguinal
1
2004
18
0.060
 Why?
Intraoperative Complications
1
2005
113
0.060
 Why?
High-Throughput Nucleotide Sequencing
2
2015
168
0.060
 Why?
Cell Line, Tumor
2
2018
1390
0.050
 Why?
Child
3
2024
6862
0.050
 Why?
Neoplasms, Second Primary
1
2024
74
0.050
 Why?
Quality of Health Care
2
2015
184
0.050
 Why?
Ischemia
1
2004
153
0.050
 Why?
Papillomavirus Infections
2
2015
167
0.050
 Why?
Perioperative Period
2
2013
22
0.050
 Why?
Trinucleotide Repeats
1
2002
4
0.050
 Why?
Liver Cirrhosis
1
2005
228
0.050
 Why?
Chromosome Aberrations
1
2024
295
0.050
 Why?
Muscles
1
2022
103
0.050
 Why?
Odds Ratio
2
2014
548
0.050
 Why?
Polymorphism, Restriction Fragment Length
1
2002
66
0.050
 Why?
Smoking
1
2005
506
0.050
 Why?
Gallium Isotopes
1
2021
2
0.050
 Why?
Accidents, Traffic
2
2017
87
0.050
 Why?
Gallium Radioisotopes
1
2021
10
0.050
 Why?
Edetic Acid
1
2021
14
0.050
 Why?
Radiotherapy, Intensity-Modulated
2
2013
174
0.050
 Why?
Geography
1
2021
61
0.050
 Why?
Androgen Antagonists
1
2021
11
0.050
 Why?
Polymorphism, Single Nucleotide
1
2024
484
0.050
 Why?
Public Health
1
2023
205
0.050
 Why?
Quarantine
1
2021
12
0.050
 Why?
Internationality
1
2021
41
0.050
 Why?
Neoplasm Metastasis
2
2017
235
0.050
 Why?
Drug Dosage Calculations
1
2020
10
0.040
 Why?
Motion
1
2020
19
0.040
 Why?
Enoxaparin
1
2020
27
0.040
 Why?
Finite Element Analysis
1
2020
10
0.040
 Why?
Drug Monitoring
1
2020
78
0.040
 Why?
Fellowships and Scholarships
1
2021
118
0.040
 Why?
Pelvis
1
2020
67
0.040
 Why?
Young Adult
2
2024
4052
0.040
 Why?
DNA-Directed RNA Polymerases
1
2019
14
0.040
 Why?
Abdomen
1
2020
77
0.040
 Why?
Heparin
1
2020
91
0.040
 Why?
Postoperative Period
1
2020
170
0.040
 Why?
Social Behavior
1
2019
69
0.040
 Why?
Urine
1
2018
23
0.040
 Why?
Adolescent
2
2024
6459
0.040
 Why?
Cytodiagnosis
1
2018
42
0.040
 Why?
Diagnostic Errors
1
2018
66
0.040
 Why?
Single-Blind Method
1
2018
114
0.040
 Why?
Image Processing, Computer-Assisted
1
2019
243
0.040
 Why?
DNA Copy Number Variations
1
2018
109
0.040
 Why?
Genome, Human
1
2018
110
0.040
 Why?
Quality-Adjusted Life Years
1
2018
63
0.040
 Why?
Sequence Analysis, RNA
1
2018
88
0.040
 Why?
Delivery of Health Care, Integrated
1
2018
46
0.040
 Why?
Hospitalization
2
2017
665
0.040
 Why?
Health Services Accessibility
2
2012
420
0.040
 Why?
Random Allocation
1
2018
288
0.040
 Why?
Nephrons
1
2016
6
0.030
 Why?
Tissue Distribution
1
2017
166
0.030
 Why?
Consensus
1
2018
158
0.030
 Why?
Dose-Response Relationship, Drug
1
2020
1356
0.030
 Why?
Hospital Communication Systems
1
2016
5
0.030
 Why?
Coitus
1
2016
18
0.030
 Why?
Failure to Thrive
1
2016
19
0.030
 Why?
Salvage Therapy
1
2017
136
0.030
 Why?
Anastomosis, Surgical
1
2016
66
0.030
 Why?
Early Detection of Cancer
1
2018
164
0.030
 Why?
Creatinine
1
2016
142
0.030
 Why?
Radiometry
1
2017
123
0.030
 Why?
Cyclin-Dependent Kinase 4
1
2015
11
0.030
 Why?
Multiplex Polymerase Chain Reaction
1
2015
11
0.030
 Why?
Genes, erbB-1
1
2015
8
0.030
 Why?
Operative Time
1
2016
72
0.030
 Why?
Tape Recording
1
2015
6
0.030
 Why?
Fever
1
2016
110
0.030
 Why?
Molecular Imaging
1
2016
54
0.030
 Why?
Socioeconomic Factors
2
2011
584
0.030
 Why?
Learning Curve
1
2015
18
0.030
 Why?
Groin
1
2015
16
0.030
 Why?
Tissue Array Analysis
1
2015
45
0.030
 Why?
Oncology Service, Hospital
1
2014
14
0.030
 Why?
Clinical Trials, Phase III as Topic
1
2015
46
0.030
 Why?
Vinblastine
1
2014
23
0.030
 Why?
Europe
1
2014
75
0.030
 Why?
North America
1
2014
66
0.030
 Why?
Incontinence Pads
1
2014
2
0.030
 Why?
Regression Analysis
1
2015
395
0.030
 Why?
In Situ Hybridization
1
2014
64
0.030
 Why?
Kidney Failure, Chronic
1
2016
199
0.030
 Why?
Amino Acid Substitution
1
2014
81
0.030
 Why?
Personal Satisfaction
1
2014
77
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2018
824
0.030
 Why?
Gene Dosage
1
2014
78
0.030
 Why?
Anxiety
1
2016
276
0.030
 Why?
Methotrexate
1
2014
73
0.030
 Why?
Ultrasonography
1
2016
438
0.030
 Why?
United States Department of Veterans Affairs
1
2015
287
0.030
 Why?
Survivors
1
2014
120
0.030
 Why?
Papillomaviridae
1
2014
102
0.030
 Why?
Dysuria
1
2013
1
0.030
 Why?
Cluster Analysis
1
2014
233
0.030
 Why?
Sequence Analysis, DNA
1
2014
236
0.030
 Why?
Prevalence
1
2016
960
0.030
 Why?
Anesthesiology
1
2014
45
0.030
 Why?
Intention to Treat Analysis
1
2013
27
0.030
 Why?
Valsalva Maneuver
1
2013
7
0.030
 Why?
Stents
1
2016
346
0.030
 Why?
Diagnostic Tests, Routine
1
2013
29
0.030
 Why?
Paclitaxel
1
2013
83
0.030
 Why?
Health Services Research
1
2013
150
0.030
 Why?
Doxorubicin
1
2014
234
0.030
 Why?
Confidence Intervals
1
2013
155
0.030
 Why?
Antibiotics, Antineoplastic
1
2013
77
0.030
 Why?
Neutropenia
1
2013
114
0.030
 Why?
Thrombocytopenia
1
2013
84
0.030
 Why?
Survival Analysis
1
2014
670
0.030
 Why?
Attitude of Health Personnel
1
2015
348
0.020
 Why?
Angiomyolipoma
1
2012
10
0.020
 Why?
Unnecessary Procedures
1
2012
20
0.020
 Why?
Tertiary Care Centers
1
2012
76
0.020
 Why?
Neoplasm, Residual
1
2013
160
0.020
 Why?
Neoplasms, Multiple Primary
1
2012
43
0.020
 Why?
Pilot Projects
1
2014
703
0.020
 Why?
Biopsy, Fine-Needle
1
2012
108
0.020
 Why?
Patient Positioning
1
2011
32
0.020
 Why?
Urination Disorders
1
2010
23
0.020
 Why?
Disease Management
1
2012
175
0.020
 Why?
Organ Size
1
2010
223
0.020
 Why?
Comorbidity
1
2012
612
0.020
 Why?
Health Status Disparities
1
2011
196
0.020
 Why?
Intraoperative Period
1
2007
45
0.020
 Why?
Erythrocyte Transfusion
1
2006
50
0.020
 Why?
Costs and Cost Analysis
1
2006
92
0.020
 Why?
Decision Trees
1
2005
19
0.020
 Why?
Portal System
1
2005
17
0.020
 Why?
Collateral Circulation
1
2005
39
0.020
 Why?
Hypertension, Portal
1
2005
20
0.020
 Why?
Reoperation
1
2006
454
0.010
 Why?
Short Bowel Syndrome
1
2004
16
0.010
 Why?
Blood Transfusion
1
2005
127
0.010
 Why?
Necrosis
1
2004
175
0.010
 Why?
Liver Transplantation
1
2005
153
0.010
 Why?
Polymorphism, Genetic
1
2002
181
0.010
 Why?
Genetic Markers
1
2002
103
0.010
 Why?
Statistics, Nonparametric
1
2002
193
0.010
 Why?
Base Sequence
1
2002
653
0.010
 Why?
Polymerase Chain Reaction
1
2002
456
0.010
 Why?
Molecular Sequence Data
1
2002
795
0.010
 Why?
Montgomery's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (437) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (28) people
_
Same Department Expand Description
Search Department